Today: 21 June 2026

DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

DocGo shares rose over 34% in after-hours trading Oct. 20, 2025, after announcing it will acquire telehealth provider SteadyMD using cash on hand. DocGo reported Q2 revenue of $80.4 million, down 51% year-over-year, and a net loss of $13.3 million. The company ended Q2 with $128.7 million in cash. A 2023 securities fraud lawsuit against DocGo remains active.
21 October 2025
·
SPRO Stock Skyrockets on Breakthrough Oral Antibiotic Data

SPRO Stock Skyrockets on Breakthrough Oral Antibiotic Data

Spero shares closed at $2.29 on Oct. 20, 2025, up 3.6%, after reporting Phase 3 trial results showing oral tebipenem HBr matched IV imipenem in overall success (58.5% vs 60.2%) at IDWeek. The stock has surged over 120% year-to-date, trading between $0.51 and $3.22. GSK plans an FDA submission in Q4. Analyst 12-month targets average $5, but ratings remain mixed following a recent Zacks downgrade.
21 October 2025
···
Replimune Stock Rockets 100% on FDA Nod – Analysts Eye Upside

Replimune Stock Rockets 100% on FDA Nod – Analysts Eye Upside

Replimune shares jumped 99% to $8.94 on Oct. 20, 2025, after the FDA accepted its resubmitted BLA for lead cancer therapy RP1 plus nivolumab, setting a PDUFA decision date for April 10, 2026. New trial data showed a 44% response rate in acral melanoma. The stock’s rebound follows a 73% plunge in July after an FDA rejection. Market cap stands near $698 million.
21 October 2025
·
Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Beyond Meat shares surged 128% to $1.47 on Oct. 20 after a volatile week driven by a short squeeze and heavy trading volumes. The company completed a debt-for-equity swap on Oct. 15, cutting $900 million in debt but diluting shareholders as outstanding shares jumped from 76.7 million to 392 million. Sales and profits continue to fall, and analysts remain broadly bearish.
21 October 2025
·
Netflix Stock Soars: Wall Street Targets $1,500 as Earnings Loom

Netflix Stock Soars: Wall Street Targets $1,500 as Earnings Loom

Netflix shares closed at $1,238.56 on Oct. 20, up 3.3% and near all-time highs ahead of Q3 earnings. Analysts expect Q3 revenue of about $11.5 billion and EPS of $6.9–7.0, with focus shifting to advertising and margins. Netflix ended Q2 with 302 million paid subscribers and $2.3 billion in free cash flow. Wall Street remains bullish, with most analysts rating the stock a “Buy.”
21 October 2025
··
Cleveland-Cliffs Stock Rockets on Tariffs and Rare-Earth Push – But Caution Remains

Cleveland-Cliffs Stock Rockets on Tariffs and Rare-Earth Push – But Caution Remains

Cleveland-Cliffs shares surged nearly 20% on Oct. 20, closing at $15.50 after Q3 results and rare-earth exploration plans. The company posted Q3 revenue of $4.73 billion and an adjusted loss of $0.45 per share, narrower than expected. Executives credited new U.S. steel tariffs for stronger demand and multi-year auto contracts. The stock is up about 42% year-to-date, far outpacing peers.
21 October 2025
·
Cookie Craze & Coffee Buzz: 7 Brew Drive-Thru and Crumbl Cookies Coming to Salisbury

Cookie Craze & Coffee Buzz: 7 Brew Drive-Thru and Crumbl Cookies Coming to Salisbury

Crumbl Cookies leased 2,300 square feet at 2717 N. Salisbury Blvd. for its first Eastern Shore Maryland store, set to open November 2025. 7 Brew will open its first Salisbury drive-thru at 1503 S. Salisbury Blvd., with construction starting soon. Crumbl operates over 1,000 locations nationwide. 7 Brew reached 500 U.S. stores by October 2025 amid rapid drive-thru coffee growth.
21 October 2025
White House U-Turn: Student Loan Forgiveness Approved for Millions After Court Deal

White House U-Turn: Student Loan Forgiveness Approved for Millions After Court Deal

The Trump administration agreed on Oct. 17, 2025, to resume canceling federal student debt for 2–2.5 million borrowers in income-driven repayment plans, under a court settlement with the AFT. The Education Department will process loan discharges for those who made 20–25 years of payments. Forgiven debt through 2025 will not trigger federal tax bills. Notices to eligible borrowers began arriving in early October.
21 October 2025
Gold Bonanza 2025: Price Soars Past $4,400 as Diamond District Frenzy Hits New York – Is $5,000 Next?

Gold Bonanza 2025: Price Soars Past $4,400 as Diamond District Frenzy Hits New York – Is $5,000 Next?

Gold hit a record $4,381 per ounce on Oct. 20 and traded near $4,300 on Oct. 21, up about 60–63% in 2025. Central banks and funds have poured $64 billion into gold ETFs this year, with retail sellers and buyers crowding New York’s Diamond District. Silver also reached a 14-year high at $54.5 per ounce. Major banks now forecast gold could reach $5,000 per ounce by 2026.
21 October 2025
···
Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple Stock Soars to Record High on iPhone 17 “Supercycle” Buzz – Will the Rally Last?

Apple stock closed at a record $262.24 on Oct. 20, up nearly 4% after iPhone 17 sales jumped 14% over last year’s launch in the U.S. and China. Loop Capital and Evercore ISI raised ratings and targets, but Jefferies downgraded the stock, citing high expectations. Apple neared a $4 trillion valuation. Earnings are due Oct. 30, with analysts expecting $101 billion in revenue.
20 October 2025
··
Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Therapeutics shares jumped 17% to $30.35 on Oct. 20, 2025, marking their highest level since early 2024. The rally followed bullish technical signals and positive clinical updates for its gene-editing therapies. Analysts at Jefferies and H.C. Wainwright reiterated Buy ratings, with price targets up to $80. Beam ended Q2 with $1.2 billion in cash, enough to fund operations into 2028.
20 October 2025
·····
Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results

Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results

Celcuity shares jumped over 40% Monday to a record near $80 after Phase 3 trial data showed its drug gedatolisib cut risk of progression or death by 76% in advanced HR+/HER2- breast cancer. The company confirmed full enrollment of the PIK3CA-mutant cohort, with final results expected by mid-2026. Needham raised its price target to $95. Celcuity’s market cap topped $2.2 billion.
20 October 2025
··
Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce Stock Surges After $60B AI Bombshell – Here’s What’s Next (Oct 20, 2025)

Salesforce shares surged nearly 7% to $253 on Thursday, Oct. 16, 2025, after unveiling new long-term revenue targets and AI plans at Dreamforce. The stock eased to close Friday near $243 and traded in the mid-$240s Monday. Year-to-date, CRM is down about 27–28%. Wall Street analysts remain mostly bullish, with average price targets around $330.
20 October 2025
····
GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

GRAIL Stock Rockets on Samsung Mega-Deal and Cancer Test Breakthrough

GRAIL shares surged 14% to a record $85.35 on Oct. 16 after Samsung agreed to invest $110 million and partner on cancer test rollout in Asia. New trial data showed Galleri’s blood test boosted early cancer detection seven-fold in a 25,000-patient study. GRAIL secured $325 million in fresh funding, extending its cash runway into 2030. Analysts remain cautious, with a consensus Hold rating and a $57 price target.
20 October 2025
···
Quantum Leap: D-Wave (QBTS) Stock Skyrockets 2000% Amid Fed Rate Cuts and AI-Fueled Quantum Breakthroughs

Quantum Gold Rush: D-Wave (QBTS) Stock Skyrockets on Quantum Breakthroughs & Hype – What’s Next?

D-Wave Quantum shares surged over 3,000% in the past year, hitting a record $46.75 before retreating to the mid-$30s. The company announced it will redeem all public warrants by Nov. 19, triggering a 4% pre-market gain. Last week, D-Wave signed an €10 million deal to deploy its quantum computer in Europe. Roth Capital raised its price target to $50 after the news.
20 October 2025
···
IonQ’s 2025 Quantum Leap: Surging Stock, Bold Ambitions & How It Compares to Rigetti and D-Wave

IonQ Stock’s Quantum Leap: Soaring 700% in a Year, $2 B Cash Boost & Bold Plans – Bubble or Breakthrough?

IonQ stock traded near $62 on Oct. 20, 2025, after swinging between $65.50 and $58.80 intraday. Shares remain up over 700% year-on-year but are down 23% from last week’s all-time high near $82 following a $2 billion share offering. IonQ announced a new quantum hub in Italy and a $2 billion funding deal. Analyst price targets range widely, with consensus forecasts in the mid-$50s.
20 October 2025
··
Alibaba’s 2025 Tech Rally: AI Gold Rush, Stock Soars & What’s Next for 9988.HK

Alibaba Stock Near 4-Year High as AI Ambitions Ignite Rally – Will BABA’s Surge Last?

Alibaba shares traded near $166 on October 20, 2025, close to their highest since 2019 and up about 85–97% year-to-date. Cloud revenue rose 26% last quarter, and management pledged a ¥380 billion tech investment. The stock briefly hit the mid-$170s before pulling back on U.S.–China tensions. Analysts remain bullish, with most price targets in the high-$180s to $240.
20 October 2025
···
AT&T Stock Faces Crucial Test: 5G Spectrum Gamble, Fiber Expansion & Earnings Loom

AT&T Stock Faces Crucial Test: 5G Spectrum Gamble, Fiber Expansion & Earnings Loom

AT&T shares closed at $26.34 Friday, up 20% year-over-year. The company will report Q3 earnings Oct. 22, with Wall Street expecting $0.54–$0.55 EPS on $30.9 billion revenue. AT&T bought $23 billion in wireless spectrum from EchoStar and acquired Lumen’s fiber business for $5.75 billion this year. Management reaffirmed 2025 guidance and announced $20 billion in share buybacks through 2027.
20 October 2025
···
1 … 1,881 1,882 1,883 1,884 1,885 … 2,088

Stock Market Today

  • Canadian Imperial Bank Of Commerce Stock May Be 25% Undervalued After Fund Changes
    June 20, 2026, 10:54 PM EDT. Canadian Imperial Bank of Commerce (TSX:CM) announced ending its Sustainable Investment Strategies ETF and raised risk on its Dividend Income Fund, prompting a reassessment by shareholders. The stock rose to CA$160.31, up 23.81% over 90 days and 180.41% over five years. Analysts' consensus price target sits slightly below the current price at CA$155.18, suggesting fair valuation based on earnings and risk outlook. However, a discounted cash flow model values the stock at CA$213.42, indicating a potential undervaluation of about 25%. Key risks include heavy Canadian mortgage exposure and rising regulatory costs that may pressure profits. Investors are weighing whether the market has fully priced in future growth potential or if CIBC represents a buying opportunity.

Latest articles

Home Depot shares finish week up as investors weigh housing numbers

Home Depot shares finish week up as investors weigh housing numbers

21 June 2026
Home Depot jumped 2.1% to $334.28 in a shortened week as Wall Street rallied, but weak U.S. housing starts and upcoming May new-home-sales data keep pressure on the home-improvement outlook; the company reaffirmed 2026 sales and earnings targets despite volatile conditions and persistent housing affordability concerns.
Go toTop